Wellington Management Group’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,306,250
Closed -$56.2M 1974
2024
Q3
$56.2M Sell
2,306,250
-670
-0% -$17.9K 0.01% 673
2024
Q2
$58M Sell
2,306,920
-24,894
-1% -$706K 0.01% 669
2024
Q1
$69.7M Sell
2,331,814
-37,517
-2% -$1.1M 0.01% 622
2023
Q4
$75.4M Sell
2,369,331
-56,050
-2% -$1.76M 0.01% 618
2023
Q3
$85.5M Buy
2,425,381
+8,244
+0.3% +$314K 0.02% 573
2023
Q2
$91.9M Sell
2,417,137
-3,783
-0.2% -$151K 0.02% 569
2023
Q1
$91.4M Sell
2,420,920
-11,949
-0.5% -$459K 0.02% 559
2022
Q4
$103M Sell
2,432,869
-928,842
-28% -$38.3M 0.02% 513
2022
Q3
$108M Sell
3,361,711
-4,917
-0.1% -$173K 0.02% 500
2022
Q2
$109M Buy
3,366,628
+32,804
+1% +$1.06M 0.02% 514
2022
Q1
$121M Buy
3,333,824
+183,578
+6% +$6.3M 0.02% 548
2021
Q4
$125M Hold
3,150,246
0.02% 577
2021
Q3
$138M Hold
3,150,246
0.02% 538
2021
Q2
$129M Hold
3,150,246
0.02% 563
2021
Q1
$103M Hold
3,150,246
0.02% 607
2020
Q4
$128M Hold
3,150,246
0.02% 524
2020
Q3
$115M Hold
3,150,246
0.02% 492
2020
Q2
$107M Hold
3,150,246
0.02% 504
2020
Q1
$66.8M Hold
3,150,246
0.02% 552
2019
Q4
$70.3M Hold
3,150,246
0.01% 671
2019
Q3
$63.8M Buy
+3,150,246
New +$62M 0.01% 663

Other funds holding GMAB

Wellington Management Group's GMAB Position: Q4 2024 in Review

Wellington Management Group sold out of Genmab (GMAB) in Q4 2024, closing a stake of 2,306,250 shares — an estimated $56.2M sold.

Wellington Management Group first reported a position in GMAB in Q3 2019 and held it in 21 quarters. The position peaked at $138M in Q3 2021. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

  • Wellington Management Group reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
  • Wellington Management Group sold 2,306,250 Genmab shares in Q4 2024, an estimated $56.2M.
  • Wellington Management Group first reported a position in Genmab in Q3 2019 and held it in 21 quarters.
  • Wellington Management Group's Genmab position peaked at $138M in Q3 2021.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.